Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/7/2026

Aspirin Use in Children with Viral Illnesses: Contraindications and Risk Management

Risk of Reye Syndrome

  • Any dose of aspirin can precipitate Reye syndrome in children < 18 years who have an acute viral illness such as influenza or varicella; therefore aspirin should be avoided for fever or viral symptoms in this population. 1, 2, 3
  • Epidemiologic data show a dramatic decline in Reye‑syndrome incidence after public health warnings against aspirin use in children, supporting a causal relationship. 1

Guideline Recommendations

  • The Advisory Committee on Immunization Practices (ACIP) recommends that aspirin or aspirin‑containing products not be administered to any person ≤ 18 years with suspected influenza. 2, 3
  • The American Diabetes Association advises that aspirin therapy should not be recommended for patients under 21 years because of the increased risk of Reye syndrome. 4
  • MMWR Recommendations and Reports identify children and adolescents aged 6 months to 18 years receiving long‑term aspirin as being at risk for Reye syndrome following influenza infection. 5, 6

Management for Children on Chronic Aspirin Therapy (e.g., Kawasaki disease, stroke prevention, juvenile arthritis)

  • Annual influenza vaccination is advised to reduce the risk of Reye syndrome in children who require chronic aspirin therapy. 7, 8, 9, 10, 11
  • Verification of varicella vaccination status is recommended before initiating or continuing chronic aspirin in these children. 7, 8, 9, 10, 11
  • Aspirin should be withheld during any suspected influenza or varicella infection, even in children on chronic therapy. 7, 8, 9, 10, 11
  • Therapeutic doses used for chronic conditions typically range from 3–5 mg/kg/day, and no cases of Reye syndrome have been reported at these doses when viral infections are avoided. 7, 8, 9, 10, 11

Clinical Presentation of Reye Syndrome

  • After a viral illness (most often influenza B), children develop protracted vomiting and encephalopathy within 24–48 hours, often while afebrile. 1
  • Altered level of consciousness, lethargy, or marked irritability may accompany the encephalopathy. 1
  • Hepatic dysfunction is evident by a > 3‑fold rise in transaminases (ALT/AST). 1
  • Serum ammonia levels are elevated, reflecting hepatic failure. 1
  • Hepatomegaly occurs in approximately 50 % of cases. 1
  • Mortality has fallen from ~50 % to < 20 % with earlier diagnosis, yet remains around 31 % in some series. 1

Epidemiologic Impact

  • The incidence of Reye syndrome fell sharply after warnings about aspirin use in children were issued, illustrating the public‑health benefit of the restriction. 1

Practical Recommendations for Clinicians

  • Over‑the‑counter “children’s aspirin” formulations are not safe during viral illness; any aspirin‑containing product carries risk. (supported by guideline statements)
  • Aspirin‑containing combination products (e.g., bismuth subsalicylate/Pepto‑Bismol) must be avoided in children with viral infections. 2, 3
  • For fever relief in children with viral illness, acetaminophen or ibuprofen should be used instead of aspirin. 2, 3
  • Children < 4 years should not receive over‑the‑counter cold medications without prior consultation with a healthcare provider. 2, 3

REFERENCES